Dr. Marisa Weiss, the Chief Medical Officer and Founder of Breastcancer.org, provides listeners with information about Breast Cancer and possible steps that can be taken to mitigate one's risk for the disease.
Key Points
Lay Summary
High-Mobility Group Box 1 expression is found to be increased in the menstrual blood, which the authors believe drive endometriosis disease development.
Key Points
Lay Summary
A French study shows macrophage migration inhibitory factor (MIF) can be a therapeutic target for endometriosis.
Key Points
Lay Summary
Dr. Tamer Seckin, MD, FACOG begins the 2017 Medical Conference by discussing the foundation, the conference, his personal story, and various endometriosis case studies he has encountered.
Key Points
Lay Summary